Companies in the oncology sector developing innovative solutions and technologies.
Explore 313 recently funded oncology companies with verified founder contact information and fundraising data.
Chemo Mouthpiece is an medical device company that develops and commercializes propriety oral cryotherapy products for cancer patients.
Calviri provides cancer treatment products by combining the immunogenic source of neoantigens with a peptide array platform.
At Speratum, we're developing a robust RNAi platform targeting key oncogenic drivers in solid tumors.
EvolveImmune Therapeutics develops a modular biotherapeutics platform specialized in immuno-oncology.
Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.
Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics.
OncoLens replaces the current labor intensive process of patient case collaboration and subsequent CoC accreditation in cancer care.
LUMICKS provides single-molecule analysis technologies for cancer research and immunotherapy.
Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.
LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy
VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.
Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.
KuriBio builds a nanotechnology platform for therapeutic applications in oncology and beyond.
CompagOs is developing a blood-based test to help oncologists detect bone metastases early with mineralized bone models.
CancerIQ provides a precision prevention platform that empowers community-based providers to prevent cancer.
Earli develops genetic constructs for early cancer detection and targeted therapy.
Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.
Hula Therapeutics is a pediatric oncology company.
Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
Apmonia Therapeutics is a biotech company that develop therapeutic strategies towards multiple types of cancer.
Tenomix's mission is to develop novel technologies that target inefficiencies in the pathology workflow and optimize cancer care.
Patient-centric cancer data and analytics platform for translational cancer biologists
Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.
Incanthera develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific
Valar Labs offers assistance services for cancer treatment through Artificial Intelligence.
The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 313 oncology companies tracked in the VCBacked database.
Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked